Cambiar Investors’s Globus Medical GMED Stock Holding History

Cambiar Investors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.96M	Buy	62,836 +4,725	+8%	+$402K	0.22%	69
2026 Q1	$5.01M	Sell	58,111 -23,433	-29%	-$2.1M	0.23%	62
2025 Q4	$7.12M	Sell	81,544 -34,936	-30%	-$2.65M	0.32%	54
2025 Q3	$6.67M	Sell	116,480 -55,919	-32%	-$3.22M	0.3%	57
2025 Q2	$10.2M	Buy	172,399 +139,548	+425%	+$9.02M	0.43%	54
2025 Q1	$2.4M	Sell	32,851 -6,474	-16%	-$535K	0.1%	99
2024 Q4	$3.25M	Sell	39,325 -3,380	-8%	-$267K	0.13%	94
2024 Q3	$3.06M	Sell	42,705 -983	-2%	-$69.4K	0.12%	94
2024 Q2	$2.99M	Hold	43,688	–	–	0.12%	93
2024 Q1	$2.34M	Sell	43,688 -997	-2%	-$53.6K	0.09%	109
2023 Q4	$2.38M	Buy	44,685 +2,371	+6%	+$116K	0.09%	122
2023 Q3	$2.1M	Buy	+42,314	New	+$2.37M	0.09%	125

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Cambiar Investors's GMED Position: Q2 2026 in Review

Cambiar Investors increased its Globus Medical (GMED) stake by 8.1% in Q2 2026, buying an estimated $402K and bringing the position to 62,836 shares worth $4.96M. The position accounts for 0.22% of the portfolio, ranked #69.

Cambiar Investors first reported a position in GMED in Q3 2023 and has held it in 12 quarters since. The position peaked at $10.2M in Q2 2025. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Cambiar Investors held 62,836 shares of Globus Medical worth $4.96M as of Q2 2026.
Cambiar Investors bought 4,725 Globus Medical shares in Q2 2026, an estimated $402K.
Globus Medical made up 0.22% of Cambiar Investors's portfolio in Q2 2026, its #69 holding.
Cambiar Investors first reported a position in Globus Medical in Q3 2023 and has held it in 12 quarters since.
Cambiar Investors's Globus Medical position peaked at $10.2M in Q2 2025.
597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Cambiar Investors's 13F filing for Q2 2026, filed 31 Jul 2026.